8 -

8 - Castellano DE, Ciruelos E, Garcia-Giron C et al. Phase II trial of biweekly irinotecan plus gemcitabine combination in refractory or relapsed small cell lung cancer (SCLC) [abstract]. Proc Am Soc Clin Oncol 2003; 21:2710.